Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case series

被引：94
|
作者：
Doi, Kent [1 ]
Ikeda, Mahoko [2 ]
Hayase, Naoki [1 ]
Moriya, Kyoji [2 ,3 ]
Morimura, Naoto [1 ]
机构：
[1] Univ Tokyo, Grad Sch Med, Dept Acute Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan
[2] Univ Tokyo Hosp, Dept Infect Control & Prevent, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan
[3] Univ Tokyo, Grad Sch Med, Dept Infect Dis, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan
[4] Univ Tokyo, Grad Sch Med, Senior Prof Off, Tokyo, Japan
来源：
CRITICAL CARE | 2020年 / 24卷 / 01期
关键词：
D O I：
10.1186/s13054-020-03078-z
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
[No abstract available]
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case series
    Kent Doi
    Mahoko Ikeda
    Naoki Hayase
    Kyoji Moriya
    Naoto Morimura
    Critical Care, 24
  • [2] Adverse events associated with nafamostat mesylate and favipiravir treatment in COVID-19 patients
    Hifumi, Toru
    Isokawa, Shutaro
    Otani, Norio
    Ishimatsu, Shinichi
    CRITICAL CARE, 2020, 24 (01):
  • [3] Adverse events associated with nafamostat mesylate and favipiravir treatment in COVID-19 patients
    Toru Hifumi
    Shutaro Isokawa
    Norio Otani
    Shinichi Ishimatsu
    Critical Care, 24
  • [4] Clinical efficacy of Nafamostat Mesylate in combination with Favipiravir for COVID-19 pneumonia treatment review article
    Abduljabbar, Maram H.
    ANNALS OF MEDICINE AND SURGERY, 2021, 68
  • [5] Nafamostat mesylate-induced hyperkalemia in critically ill patients with COVID-19: Four case reports
    Okajima, Masaki
    Takahashi, Yoshinori
    Kaji, Takaaki
    Ogawa, Naohiko
    Mouri, Hideyuki
    WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (21) : 5320 - 5325
  • [6] Nafamostat mesylate-induced hyperkalemia in critically ill patients with COVID-19: Four case reports
    Masaki Okajima
    Yoshinori Takahashi
    Takaaki Kaji
    Naohiko Ogawa
    Hideyuki Mouri
    World Journal of Clinical Cases, 2020, (21) : 5320 - 5325
  • [7] Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID-19
    Irie, Kei
    Nakagawa, Atsushi
    Fujita, Hirotoshi
    Tamura, Ryo
    Eto, Masaaki
    Ikesue, Hiroaki
    Muroi, Nobuyuki
    Tomii, Keisuke
    Hashida, Tohru
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (05): : 880 - 885
  • [8] Liver injury in critically ill patients with COVID-19: a case series
    Filipe S. Cardoso
    Rui Pereira
    Nuno Germano
    Critical Care, 24
  • [9] Covid-19 in Critically Ill Patients in the Seattle Region - Case Series
    Bhatraju, Pavan K.
    Ghassemieh, Bijan J.
    Nichols, Michelle
    Kim, Richard
    Jerome, Keith R.
    Nalla, Arun K.
    Greninger, Alexander L.
    Pipavath, Sudhakar
    Wurfel, Mark M.
    Evans, Laura
    Kritek, Patricia A.
    West, T. Eoin
    Luks, Andrew
    Gerbino, Anthony
    Dale, Chris R.
    Goldman, Jason D.
    O'Mahony, Shane
    Mikacenic, Carmen
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (21): : 2012 - 2022
  • [10] Liver injury in critically ill patients with COVID-19: a case series
    Cardoso, Filipe S.
    Pereira, Rui
    Germano, Nuno
    CRITICAL CARE, 2020, 24 (01):
12345